Bill · H.R. 10272· House(119-HR-10272)
End Gas Station Heroin Act
- Introduced
- 9/3/2026
- Last activity
- 9/3/2026 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sponsored by
- Lance Gooden
- Cosponsors
- - 4 - 0
- Introduced
- In Committee
What this bill would do
This bill is known as the End Gas Station Heroin Act. It amends the Controlled Substances Act to schedule MGM-15 and MGM-16 as Schedule I controlled substances. The bill also schedules synthetic 7-hydroxymitragynine and mitragynine pseudoindoxyl as Schedule I substances when they are above a specific threshold. Additionally, the legislation expands enforcement actions against drug manufacturers and distributors of emerging synthetic opioids.
Yes· 3 of 9
Does this do more about addiction and overdose deaths?+7
Targets the commercial distribution of potent synthetic opioids to reduce public health risks.
Would children be better off under this?+5
Reduces the availability of dangerous synthetic opioids in commercial channels.
Would people in their twenties and thirties be better off under this?+5
Reduces the availability of dangerous synthetic opioids in commercial channels.
The opposite
Would business owners be better off under this?-3
Imposes strict penalties on manufacturers and distributors of specific synthetic compounds.
Does this make it easier to run a small business?-2
Increases legal risks for businesses selling products containing specific synthetic kratom alkaloids.
Who it would affect, and how
Potential Positive Impacts for People
-
Protection from synthetic opioid manufacturing: Section 3(a) and Section 3(d) treat covered emerging synthetic opioids as Schedule I controlled substances for the purpose of prohibiting and enforcing against their knowing or intentional manufacture, distribution, or possession with intent to manufacture or distribute, which could help protect people from dangerous emerging drugs.
-
Protection for simple possession: Section 3(b) and Section 3(e) ensure that no person is subject to criminal or civil enforcement based solely on the purchase, receipt, simple possession, or personal use of a covered emerging synthetic opioid, protecting everyday individuals from being jailed just for personal consumption.
Potential Negative Impacts for People
- Burdens on specific substances: Section 2 places restrictions and schedules 7-hydroxymitragynine and mitragynine pseudoindoxyl under Schedule I if they exceed specific concentration thresholds or are produced through manufacturing processes, which could heavily burden businesses and consumers who rely on these specific substances.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Children+5Good For Young Adults+5Good For Low Income Households+3Good For Rural Residents+3Good For Urban Residents+3Good For Business Owners-3
- Healthcare
- Improves Opioid Crisis Response+7
- Governance And Ideology
- Increases Federal Power+3Improves Due Process+2
- Economy And Finance
- Improves Consumer Protection+5Improves Small Business Support-2
- 9/24/2026
- 1 Cosponsor added.
- 9/16/2026
- 1 Cosponsor added.
- 9/10/2026
- 1 Cosponsor added.
- 9/4/2026
- 1 Cosponsor added.
- 9/3/2026
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Randy FineRepublican · Florida
Barry MooreRepublican · Alabama
Mariannette Miller-MeeksRepublican · Iowa
Richard McCormickRepublican · Georgia